NYSE · LUMN

Lumen Technologies, Inc.

$6.34 -$0.19 (-2.91%) 1D After hours

Key Metrics

$6.73B
Market cap
P/E · TTM
$12.12B
Revenue · TTM
−$1.74B
Net income
EPS · TTM $-1.75
Dividend yield
Free cash flow $447.00M
Beta · 1Y 3.05
EBITDA · TTM $406.00M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 17
    From its May 29 high, the share price fell 43%.

    Peak close $10.99 on May 29; trough close $6.28 on Jul 17. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -43%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 6
    The stock moved +29.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6
  • Feb 4
    The stock moved -21.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$6.73B
Enterprise value$18.06B
Shares outstanding1.0B
52-wk range$3.37 – $11.95
Avg volume · 20D16.4M
Net cash −$11.34B
Book value / share$-1.33
IndustryTelephone Communications (No Radiotelephone)
ExchangeNYSE
About Lumen Technologies, Inc.
IPO dateOct 24, 1978
Employees21000

Lumen Technologies is one of the largest telecommunications carriers serving global enterprises.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.56
P/FCF15.05
EV/EBITDA44.49
EV/Sales1.49
Graham №

Profitability

Gross
Operating -18.9%
Net -14.3%
FCF 3.7%
ROE / ROIC 407.5% · -17.3%

Financial Health

Current ratio0.99
Quick ratio
Debt / equity-9.84
Debt / EBITDA 31.92
Net cash −$11.34B
Working capital−$50.00M

Cash Flow · TTM

Operating CF $4.97B
Capex −$4.52B
Free cash flow $447.00M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings